RAFAEL HOLDINGS, INC. Fair Value Adjustment of Warrants
RAFAEL HOLDINGS, INC. (RFL) had Fair Value Adjustment of Warrants of $0 as of 2025-03-25, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. fair value adjustment of warrants for fiscal 2023 was $79.00K.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 12 month |
|---|---|---|
| 2025-03-25 | $0.00 10-Q · filed 2026-06-11 | |
| 2023-07-31 | $79.00K 10-K · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |